Troglitazone Improves Psoriasis and Normalizes Models of Proliferative Skin Disease

Abstract

Peroxisome proliferator-activated receptor-gamma might be a useful intracellular target for the treatment of psoriasis; further study is needed to assess the clinical value of ligands for PPARgamma, including troglitazone.